If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?This is my first time initiating coverage of BridgeBio Oncology Therapeutics ( BBOT ), and the first time the company has been covered for Seeking Alpha.Edmund Ingham is a biotech consultant. He has been covering b ...